Description: Brain+ A/S develops digital therapeutics for Alzheimer's and dementia. The company develops cognitive stimulation therapy (CST), a therapy that treats the main symptoms of dementia; Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, memory test for early detection and monitoring of Alzheimer's. In addition, it develops an interface for clinicians to track and trace the patient's treatment progress. The company was incorporated in 2012 and is based in Copenhagen, Denmark. Brain+ A/S was formerly a subsidiary of Brain+ Holding ApS.
Home Page: www.brain-plus.com
KOebmagergade 53
Copenhagen,
1150
Denmark
Phone:
45 21 75 40 38
Officers
| Name | Title |
|---|---|
| Mr. Kim Baden-Kristensen | Founder, CEO & MD |
| Mr. Rasmus Højengaard | Founder and CCO |
| Ms. Helle Behrndtz Jensen | Fin. Mang. |
| Mr. Bertil S. Jessen | Chief Financial Officer |
| Ms. Paula Petcu | Chief Technology Officer |
| Simon Nielsen | Chief Science & Innovation Officer |
| Mr. Bjarke Langbol Panduro | Marketing & Product Mang. |
Exchange: CO
Country: DK
Currency: Danish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.8358 |
| Price-to-Sales TTM: | 4.9478 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 20 |